Market Overview:
The India pharmaceutical packaging market size reached US$ 1,787.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,196.6 Million by 2032, exhibiting a growth rate (CAGR) of 6.67% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 1,787.9 Million |
Market Forecast in 2032
|
US$ 3,196.6 Million |
Market Growth Rate 2024-2032 |
6.67% |
Pharmaceutical packaging aids in the storage, protection, traceability, and identification of different pharmaceutical products. It involves primary packaging that safeguards medicinal products from environmental, chemical, mechanical and other hazards. It also includes secondary packaging that provides information about different drugs and tertiary packaging, which prevents damage to products and assists in bulk handling and shipping. Some of the commonly used pharmaceutical packaging in India are ampoules, bottles, vials, blister packs, and sachet packaging.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
India Pharmaceutical Packaging Market Trends:
The increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular and respiratory diseases, represents one of the key factors bolstering the growth of the market in India. Moreover, the Government of India has introduced the Production Linked Incentive (PLI) scheme for encouraging domestic manufacturing of critical key starting materials (KSMs)/ drug intermediates (DIs) and active pharmaceutical ingredients (APIs) to reduce import dependence. It is also establishing health and wellness centres (HWCs) to deliver comprehensive primary health care (CPHC) that cover non-communicable diseases and maternal and child health services, comprising free essential drugs and diagnostic services. Furthermore, increasing exports of generic medicines and other pharmaceutical products, coupled with the rising adoption of new regulatory standards for packaging recycling, is positively influencing the market. Apart from this, the development of child-resistant packaging (CRP), which can minimize the risk of poisoning among children through the ingestion of prescription drugs and over the counter (OTC) medicines, is projected to stimulate the market growth in India.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the India pharmaceutical packaging market report, along with forecasts at the country and regional level from 2024-2032. Our report has categorized the market based on material type, product type and end user.
Breakup by Material Type:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Breakup by Product Type:
- Bottles
- Vials and Ampoules
- Syringes
- Tubes
- Caps and Closures
- Pouches
- Labels
- Others
Breakup by End User:
Breakup by Region:
- North India
- West and Central India
- South India
- East India
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amcor plc, AptarGroup Inc., EPL Limited, Huhtamaki PPL Ltd, Nipro Corporation, Parekhplast India Limited, SCHOTT Pharmaceutical Packaging, SGD Pharma, UFlex Limited and West Pharmaceutical Services Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Million |
Segment Coverage |
Material Type, Product Type, End User, Region |
Region Covered |
North India, West and Central India, South India, East India |
Companies Covered |
Amcor plc, AptarGroup Inc., EPL Limited, Huhtamaki PPL Ltd, Nipro Corporation, Parekhplast India Limited, SCHOTT Pharmaceutical Packaging, SGD Pharma, UFlex Limited and West Pharmaceutical Services Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |